Tech Company Financing Transactions
Strategikon Pharma Funding Round
Strategikon Pharma closed a Series A financing round on 4/27/2021. Backers included Osage Partners, Bascom Group and Wing Venture Capital.
Transaction Overview
Company Name
Announced On
4/27/2021
Transaction Type
Venture Equity
Amount
Unknown
Round
Series A
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare IT
Mailing Address
1 Sansome St. 35th Floor 40621
San Francisco, CA 94104
USA
San Francisco, CA 94104
USA
Phone
Website
Email Address
Overview
Clinical Maestro, Strategikon's flagship product, is a cloud-based platform that modernizes outsourcing for clinical programs. It enables all participants in clinical trials, Sponsor Companies, Vendors and Service Providers, to plan studies, model and manage clinical contracts in an entirely systematic way.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Anca Copaescu
Chief Operating Officer
Paulo Carvalho
VP - Bus. Development
Farah Ahmad
VP - Bus. Development
Michael Quinn
VP - Bus. Development
Oren Sebag
VP - Customer Service
Sandy Imboden
VP - Marketing
Karen Wills
Browse more venture capital transactions:
Prev: 4/27/2021: Weav venture capital transaction
Next: 4/27/2021: Calmerry venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC investment data records reported here come from company press releases and news coverage. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs